O-03: ETAVOPIVAT TREATMENT FOR UP TO 12 WEEKS IN PATIENTS WITH SICKLE CELL DISEASE IS WELL TOLERATED AND IMPROVES RED BLOOD CELL HEALTH

por M., TELEN, R., BROWN, R., HAGAR, M., IDOWU, I., OSUNKWO, T., KALFA, F., KUYPERS, J., GEIB, P., SCHROEDER, E., WU, P., KELLY, S., SARAF
Publicado 2022

Lucid dreaming increased during the COVID-19 pandemic: An online survey

por P., Kelly, T., Macêdo, T., Felipe, M., Maia, A., Suely, G., Herminia, M., Jatahy, L., Gomes, L., Barroso, T. Z., Lima, B., Holzinger, S., Ribeiro, S., Mota-Rolim
Publicado 2022

Rationale and design of the Exercise Intensity Trial (EXCITE): A randomized trial comparing the effects of moderate versus moderate to high-intensity aerobic training in women with...

por Jones, Lee W, Douglas, Pamela S, Eves, Neil D, Marcom, P Kelly, Kraus, William E, Herndon, James E, Inman, Brant A, Allen, Jason D, Peppercorn, Jeffrey
Publicado 2010

Analysis of Sociodemographic, Clinical, and Genomic Factors Associated With Breast Cancer Mortality in the Linked Surveillance, Epidemiology, and End Results and Medicare Database

por Robinson, Timothy J., Wilson, Lauren E., Marcom, P. Kelly, Troester, Melissa, Lynch, Charles F., Hernandez, Brenda Y., Parrilla, Edgardo, Brauer, Heather Ann, Dinan, Michaela A.
Publicado 2021

Verteporfin treatment controls morphology, phenotype, and global gene expression for cells of the human nucleus pulposus

por Fearing, Bailey V., Speer, Julie E., Jing, Liufang, Kalathil, Aravind, P. Kelly, Michael, M. Buchowski, Jacob, P. Zebala, Lukas, Luhmann, Scott, C. Gupta, Munish, A. Setton, Lori
Publicado 2020

An integration of complementary strategies for gene-expression analysis to reveal novel therapeutic opportunities for breast cancer

por Bild, Andrea H, Parker, Joel S, Gustafson, Adam M, Acharya, Chaitanya R, Hoadley, Katherine A, Anders, Carey, Marcom, P Kelly, Carey, Lisa A, Potti, Anil, Nevins, Joseph R, Perou, Charles M
Publicado 2009

Correction: An integration of complementary strategies for gene-expression analysis to reveal novel therapeutic opportunities for breast cancer

por Bild, Andrea H, Parker, Joel S, Gustafson, Adam M, Acharya, Chaitanya R, Hoadley, Katherine A, Anders, Carey, Marcom, P Kelly, Carey, Lisa A, Potti, Anil, Nevins, Joseph R, Perou, Charles M
Publicado 2011

Impact of hormone receptor status on patterns of recurrence and clinical outcomes among patients with human epidermal growth factor-2-positive breast cancer in the National Compreh...

por Vaz-Luis, Ines, Ottesen, Rebecca A, Hughes, Melissa E, Marcom, P Kelly, Moy, Beverly, Rugo, Hope S, Theriault, Richard L, Wilson, John, Niland, Joyce C, Weeks, Jane C, Lin, Nancy U
Publicado 2012

A phase Ib study of capecitabine and ziv-aflibercept followed by a phase II single-arm expansion cohort in chemotherapy refractory metastatic colorectal cancer

por Strickler, John H., Rushing, Christel N., Niedzwiecki, Donna, McLeod, Abigail, Altomare, Ivy, Uronis, Hope E., Hsu, S. David, Zafar, S. Yousuf, Morse, Michael A., Chang, David Z., Wells, James L., Blackwell, Kimberly L., Marcom, P. Kelly, Arrowood, Christy, Bolch, Emily, Haley, Sherri, Rangwala, Fatima A., Hatch, Ace J., Nixon, Andrew B., Hurwitz, Herbert I.
Publicado 2019

Circulating tumor cell number and endocrine therapy index in ER positive metastatic breast cancer patients

por Paoletti, Costanza, Regan, Meredith M., Niman, Samuel M., Dolce, Emily M., Darga, Elizabeth P., Liu, Minetta C., Marcom, P. Kelly, Hart, Lowell L., Smith, John W., Tedesco, Karen L., Amir, Eitan, Krop, Ian E., DeMichele, Angela M., Goodwin, Pamela J., Block, Margaret, Aung, Kimberly, Brown, Martha E., McCormack, Robert T., Hayes, Daniel F.
Publicado 2021

Perspectives on Inflammatory Breast Cancer (IBC) Research, Clinical Management and Community Engagement from the Duke IBC Consortium

por Devi, Gayathri R., Hough, Holly, Barrett, Nadine, Cristofanilli, Massimo, Overmoyer, Beth, Spector, Neil, Ueno, Naoto T., Woodward, Wendy, Kirkpatrick, John, Vincent, Benjamin, Williams, Kevin P., Finley, Charlotte, Duff, Brandi, Worthy, Valarie, McCall, Shannon, Hollister, Beth A., Palmer, Greg, Force, Jeremy, Westbrook, Kelly, Fayanju, Oluwadamilola, Suneja, Gita, Dent, Susan F., Hwang, E. Shelley, Patierno, Steven R., Marcom, P. Kelly
Publicado 2019

Evaluation of Alisertib Alone or Combined With Fulvestrant in Patients With Endocrine-Resistant Advanced Breast Cancer: The Phase 2 TBCRC041 Randomized Clinical Trial

por Haddad, Tufia C., Suman, Vera J., D’Assoro, Antonino B., Carter, Jodi M., Giridhar, Karthik V., McMenomy, Brendan P., Santo, Katelyn, Mayer, Erica L., Karuturi, Meghan S., Morikawa, Aki, Marcom, P. Kelly, Isaacs, Claudine J., Oh, Sun Young, Clark, Amy S., Mayer, Ingrid A., Keyomarsi, Khandan, Hobday, Timothy J., Peethambaram, Prema P., O’Sullivan, Ciara C., Leon-Ferre, Roberto A., Liu, Minetta C., Ingle, James N., Goetz, Matthew P.
Publicado 2023

Identifying homologous recombination deficiency in breast cancer: genomic instability score distributions differ among breast cancer subtypes

por Lenz, Lauren, Neff, Chris, Solimeno, Cara, Cogan, Elizabeth S., Abramson, Vandana G., Boughey, Judy C., Falkson, Carla, Goetz, Matthew P., Ford, James M., Gradishar, William J., Jankowitz, Rachel C., Kaklamani, Virginia G., Marcom, P. Kelly, Richardson, Andrea L., Storniolo, Anna Maria, Tung, Nadine M., Vinayak, Shaveta, Hodgson, Darren R., Lai, Zhongwu, Dearden, Simon, Hennessy, Bryan T., Mayer, Erica L., Mills, Gordon B., Slavin, Thomas P., Gutin, Alexander, Connolly, Roisin M., Telli, Melinda L., Stearns, Vered, Lanchbury, Jerry S., Timms, Kirsten M.
Publicado 2023

Whole Genome Analysis Informs Breast Cancer Response to Aromatase Inhibition

por Ellis, Matthew J., Ding, Li, Shen, Dong, Luo, Jingqin, Suman, Vera J., Wallis, John W., Van Tine, Brian A., Hoog, Jeremy, Goiffon, Reece J., Goldstein, Theodore C., Ng, Sam, Lin, Li, Crowder, Robert, Snider, Jacqueline, Ballman, Karla, Weber, Jason, Chen, Ken, Koboldt, Daniel C., Kandoth, Cyriac, Schierding, William S., McMichael, Joshua F., Miller, Christopher A., Lu, Charles, Harris, Christopher C., McLellan, Michael D., Wendl, Michael C., DeSchryver, Katherine, Allred, D. Craig, Esserman, Laura, Unzeitig, Gary, Margenthaler, Julie, Babiera, G.V., Marcom, P. Kelly, Guenther, J.M., Leitch, Marilyn, Hunt, Kelly, Olson, John, Tao, Yu, Maher, Christopher A., Fulton, Lucinda L., Fulton, Robert S., Harrison, Michelle, Oberkfell, Ben, Du, Feiyu, Demeter, Ryan, Vickery, Tammi L., Elhammali, Adnan, Piwnica-Worms, Helen, McDonald, Sandra, Watson, Mark, Dooling, David J., Ota, David, Chang, Li-Wei, Bose, Ron, Ley, Timothy J., Piwnica-Worms, David, Stuart, Joshua M., Wilson, Richard K., Mardis, Elaine R.
Publicado 2012

Multiomics in primary and metastatic breast tumors from the AURORA US network finds microenvironment and epigenetic drivers of metastasis

por Garcia-Recio, Susana, Hinoue, Toshinori, Wheeler, Gregory L., Kelly, Benjamin J., Garrido-Castro, Ana C., Pascual, Tomas, De Cubas, Aguirre A., Xia, Youli, Felsheim, Brooke M., McClure, Marni B., Rajkovic, Andrei, Karaesmen, Ezgi, Smith, Markia A., Fan, Cheng, Ericsson, Paula I. Gonzalez, Sanders, Melinda E., Creighton, Chad J., Bowen, Jay, Leraas, Kristen, Burns, Robyn T., Coppens, Sara, Wheless, Amy, Rezk, Salma, Garrett, Amy L., Parker, Joel S., Foy, Kelly K., Shen, Hui, Park, Ben H., Krop, Ian, Anders, Carey, Gastier-Foster, Julie, Rimawi, Mothaffar F., Nanda, Rita, Lin, Nancy U., Isaacs, Claudine, Marcom, P. Kelly, Storniolo, Anna Maria, Couch, Fergus J., Chandran, Uma, Davis, Michael, Silverstein, Jonathan, Ropelewski, Alexander, Liu, Minetta C., Hilsenbeck, Susan G., Norton, Larry, Richardson, Andrea L., Symmans, W. Fraser, Wolff, Antonio C., Davidson, Nancy E., Carey, Lisa A., Lee, Adrian V., Balko, Justin M., Hoadley, Katherine A., Laird, Peter W., Mardis, Elaine R., King, Tari A., Perou, Charles M.
Publicado 2022